Indian-made COVID-19 vaccines have been supplied to 71 countries across the world

Bangladesh has received the maximum number of Made-in-India COVID-19 vaccines, with 90 lakh (9 million) doses having been supplied to the country so far.

Of this, 20 lakh (2 million) doses were delivered as a grant from India on January 21. This is the highest number of vaccine doses supplied by India to any country as a grant.

The remaining 70 lakh doses were sent to Bangladesh in two tranches under commercial arrangement with the vaccine manufacturers, according to information available on the website of the Ministry of External Affairs (MEA).

Indian-made COVID-19 vaccines have been supplied to 71 countries in different regions of the world.

Myanmar has received the second-largest number of vaccines doses as grant at 17 lakhs (1.7 million), followed by Nepal at 10 lakhs (1 million), according to the MEA figures.

The number of vaccines doses sent as grant, under commercial arrangement, and through the COVAX initiatives was 586.4 lakh (58.64 million) at 10 am on Tuesday morning.

This includes 81.25 lakh vaccines as grant, 339.67 lakh vaccines under commercial arraignment, and 165.48 lakh through COVAX.

The Indian government maintains that sending vaccines to other countries will not impact the countrywide vaccination campaign as there is sufficient COVID-19 vaccine supply.

In a written reply to a question in the Rajya Sabha in Tuesday, Minister of State for Health and Family Welfare Ashwini Kumar Choubey pointed out that the MEA had received several requests for the supply of Indian manufactured COVID-19 vaccines from various foreign countries.

The minister's reply referred to the MEA Press Release of January 19, which had stated that, "Keeping in view the domestic requirements of the phased rollout, India will continue to supply COVID-19 vaccines to partner countries over the coming weeks and months in a phased manner".

"It will be ensured that domestic manufacturers will have adequate stocks to meet domestic requirements while supplying abroad," the MEA had emphasized.